Home › Funds › ORBIMED ADVISORS LLC › TMO
ORBIMED ADVISORS LLC position in TMO
THERMO FISHER SCIENTIFIC INC · Industrials
ORBIMED ADVISORS LLC reported holding 90,700 shares of TMO (THERMO FISHER SCIENTIFIC INC) in its Q2 2026 13F filing — a position valued at US$45.5M, representing 0.91% of its reported portfolio and ranking #34 among its reported holdings. ORBIMED ADVISORS LLC has disclosed TMO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's TMO position evolved
ORBIMED ADVISORS LLC first disclosed a stake in TMO in Q3 2023 at 143,800 shares (US$72.8M). The position peaked in Q1 2024 at 132,000 shares, worth US$76.7M. Across 12 filings, ORBIMED ADVISORS LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 90,700 shares valued at US$45.5M — an increase of 44,200 shares quarter over quarter.. Notable position changes include a 53% increase in Q1 2025 (shares fell 16% over the following quarter), a 64% trim in Q2 2025 (shares rose 20% over the following quarter), a 95% increase in Q2 2026 (shares rose 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 143.80K | $72.79M | New |
| Q4 2023 | 143.80K | $76.33M | Hold |
| Q1 2024 | 132.00K | $76.72M | Reduce |
| Q2 2024 | 132.00K | $73.00M | Hold |
| Q3 2024 | 84.40K | $52.21M | Reduce |
| Q4 2024 | 84.40K | $43.91M | Hold |
| Q1 2025 | 129.00K | $64.19M | Add |
| Q2 2025 | 46.50K | $18.85M | Reduce |
| Q3 2025 | 46.50K | $22.55M | Hold |
| Q4 2025 | 46.50K | $26.94M | Hold |
| Q1 2026 | 46.50K | $22.86M | Hold |
| Q2 2026 | 90.70K | $45.47M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TMO and 13F data
TMO (THERMO FISHER SCIENTIFIC INC) is a Industrials company. 29 other funds we track also report a position in TMO — the largest reported positions include Vanguard Group (US$19.78B), Fidelity Management & Research (FMR) (US$7.06B), Franklin Resources (US$3.65B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TMO
- Vanguard Group 34.13M sh · $19.78B · Q4 2025
- Fidelity Management & Research (FMR) 14.08M sh · $7.06B · Q2 2026
- Franklin Resources 7.27M sh · $3.65B · Q2 2026
- MFS Investment Management 2.97M sh · $2.28B · Q2 2026
- BNY Mellon 3.94M sh · $1.97B · Q2 2026
- Dodge & Cox 3.05M sh · $1.53B · Q2 2026
- DODGE & COX 3.05M sh · $1.53B · Q2 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 2.76M sh · $1.38B · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 2.74M sh · $1.37B · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held TMO?
ORBIMED ADVISORS LLC has disclosed TMO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in TMO?
As of Q2 2026, ORBIMED ADVISORS LLC holds 90.70K shares of TMO (THERMO FISHER SCIENTIFIC INC), valued at $45.47M, representing 0.91% of its reported portfolio and ranking #34.
Has ORBIMED ADVISORS LLC been buying or selling TMO?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in TMO. The position peaked in Q1 2024 at 132.00K shares.
Which other funds hold TMO?
Other major institutional holders of TMO include Vanguard Group, Fidelity Management & Research (FMR), Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.